Keyser Family Cancer Center at Advocate Hope Children's Hospital — Oak Lawn, Illinois

Keyser Family Cancer Center at Advocate Hope Children's Hospital is a clinical research site located in Oak Lawn, Illinois, United States 60453.

Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Keyser Family Cancer Center at Advocate Hope Children's Hospital has participated in 6 clinical trials.

Therapeutic areas: Leukemia, Brain Tumor, Central Nervous System Tumor.

Sponsors: Children's Oncology Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oak Lawn

Browse all research sites in Illinois · View every site in Oak Lawn

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Keyser Family Cancer Center at Advocate Hope Children's Hospital?

Keyser Family Cancer Center at Advocate Hope Children's Hospital has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Keyser Family Cancer Center at Advocate Hope Children's Hospital conducted?

Keyser Family Cancer Center at Advocate Hope Children's Hospital has 6 clinical trials on record. Their work covers Leukemia, Brain Tumor, Central Nervous System Tumor.

Is Keyser Family Cancer Center at Advocate Hope Children's Hospital accredited by Crixeo Clinical Trials?

Keyser Family Cancer Center at Advocate Hope Children's Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Keyser Family Cancer Center at Advocate Hope Children's Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.